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Caveolins constitute the coat of caveolae, specialized do-
mains of the plasma membrane. A large body of evidence
suggests that caveolae are enriched in sphingolipids and
cholesterol. Besides a role in signal transduction and in the
sorting of membrane components, a diverse range of func-
tions has been assigned to the caveolins in the cellular ho-
meostasis of cholesterol. Cholesterol is essential for nu-
merous membrane processes, and its concentration in the
cell is governed by a delicate sensor–effector mechanism.
However, the basic rules that govern the distribution and
dynamics of cholesterol in cells are not understood, a situ-
ation that may be changed by an improved insight in the
actions of cholesterol-binding proteins like caveolins.
Three papers in the present issue report unexpectedly that
caveolins can be found on the surface of cytoplasmic lipid
droplets (Fujimoto et al., 2001; Ostermeyer et al., 2001;
Pol et al., 2001). Lipid droplets consist of apolar lipids and
are thought to serve as inert energy storage sites. Caveolin
transport to the lipid droplets may represent an “over-
flow” pathway from the ER under conditions where their
concentration in the ER is enhanced (Ostermeyer et al.,
2001). More sensational proposals are that caveolin on
lipid droplets is a key component in maintaining the cellu-
lar cholesterol balance (Pol et al., 2001) and that caveolin
populates a raft-like membrane domain on the droplet
surface that is involved in intracellular signaling (Fujimoto
et al., 2001).
 
Cholesterol Homeostasis
 
Cells keep their cholesterol content under tight transcrip-
tional control. One essential element of the control ma-
chinery is a cholesterol sensor in the ER membrane
(Brown and Goldstein, 1997). Apparently, the cholesterol
content of the ER accurately reflects the cholesterol status
of the cell. This is remarkable because most cellular cho-
lesterol resides in the plasma membrane with very low lev-
els in the ER (Lange et al., 1999). In addition, not all
changes in cellular cholesterol occur at the ER. Besides
cholesterol synthesis in ER and peroxisomes (Olivier and
Krisans, 2000), cholesterol is released from lipoprotein
cholesterol esters in late endosomes and lysosomes, and in
lipid droplets. Cholesterol is removed from cells by “re-
verse transport” onto high density lipoprotein at the out-
side of the plasma membrane, mediated by the ATP-bind-
ing cassette transporter A1, ABCA1, and by esterification
in the ER membrane by acyl CoA–cholesterol acyltrans-
ferases, after which the cholesterol esters are stored in
lipid droplets or secreted as lipoproteins. In specialized
cells, cholesterol is converted to bile acids or steroid hor-
mones in the mitochondria. The fact that the cellular cho-
lesterol level can be sensed in the ER even though the
bulk of the cellular cholesterol is in the plasma membrane
and endosomes where an essential part of the cholesterol
in- and efflux takes place, raises the question how the cel-
lular cholesterol pools are connected.
As a basic rule, the intracellular disposition of choles-
terol is governed by cholesterol’s high affinity for sphin-
golipids and saturated phospholipids, which are highly en-
riched in the plasma membrane, the trans-Golgi network
and endocytic membranes. The ER contains unsaturated
glycerophospholipids, with particularly low affinity for
cholesterol. Sphingomyelin and the complex glycosphin-
golipids are synthesized on the lumenal surface of the
Golgi complex and cannot spontaneously translocate
across the Golgi membrane or the plasma membrane.
Thus, sphingolipids are limited to the exo- and endocytic
vesicular transport circuits, and virtually absent from mito-
chondria, peroxisomes, and also from lipid droplets (Zin-
ser and Daum, 1995). The concentration gradient of sphin-
golipids (and thereby of cholesterol) across the Golgi
stack appears to be steep, now that more and more en-
zymes of sphingolipid biosynthesis have been assigned to
the trans-Golgi network. The gradient is maintained by
forward transport of the sphingolipids towards the plasma
membrane. In our current view, sphingolipids aggregate in
the Golgi membrane due to their structural properties.
These lateral domains, “afts,” are preferentially excluded
from the retrograde pathway, which probably involves
both a physical principle, sphingolipid membranes have a
lower tendency to bend, and the segregation of mem-
brane-spanning proteins that function in vesiculation.
 
Cholesterol is essential for the segregation of the sphin-
golipid domains. By keeping these lipids in a fluid state it al-
lows the coexistence of two fluid domains, a liquid-ordered
sphingolipid-cholesterol domain beside a liquid-disordered
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domain of unsaturated glycerophospholipids (Brown and
London, 2000). The partitioning of cholesterol with sphin-
golipids and their anterograde vesicular transport, with a
typical half-time of 30 min between ER and plasma mem-
brane, describes only part of cholesterol’s itinerary in the
cell. Cholesterol equilibrates across aqueous spaces as a
monomer with a half-time of 1–2 h (Phillips et al., 1987). A
final transport step that is relevant to understanding the
partitioning of cholesterol is its translocation across lipid bi-
layers. The literature on this is confused with half-times be-
tween seconds and hours, but the transbilayer translocation
of cholesterol across plasma membranes probably displays
a half-time of 1–2 h (Brasaemle et al., 1988).
Cholesterol accumulates in late endosomes in a variety
of diseases and experimental conditions (Liscum and
Munn, 1999). In all cases, there appears to be an accumula-
tion of lipids that can trap cholesterol (like sphingomyelin,
half-time of cholesterol desorption is 
 
z
 
15 h; Phillips et al.,
1987), and a defect in vesicle budding from and into late
endosomes. The exact order of events is presently unclear,
but two proteins involved in cholesterol transport, the Nie-
mann-Pick type C disease protein (Davies et al., 2000) and
the Tangier disease ABCA1 protein (Hamon et al., 2000),
may be lipid translocators. Proper hydrolysis and removal
of lipids, especially sphingolipids like sphingosine, from
endosomes may be required for allowing vesicular trans-
port of cholesterol from the endosomes to Golgi and
plasma membrane (Fig. 1).
 
Caveolins and Cholesterol
 
Many experimental studies have suggested a function in
cholesterol transport for caveolae and their characteristic
protein caveolin. Caveolae have been defined morphologi-
cally as flask-shaped invaginations of the plasma mem-
brane, and were found to be involved in endocytosis and
transcytosis. In contrast to clathrin-coated pits, where a
clathrin lattice is attached to the cytosolic tails of mem-
brane spanning proteins via adaptor proteins, the cytosolic
side of caveolae is covered by a protein oligomer that is di-
rectly attached to the lipid phase of the membrane. The
protein, caveolin of 21–24 kD contains hydrophilic NH
 
2
 
-
and COOH-terminal domains that stick into the cytosol,
whereas the central domain of 33 hydrophobic amino ac-
ids dips into the lipid phase in a hairpin configuration. The
family presently consists of caveolins-1 and -3, which dis-
play 85% similarity, and caveolin-2, which lacks the NH
 
2
 
terminus of caveolins-1 and -3, and occurs as 
 
a
 
- and 
 
b
 
-iso-
forms. Caveolin-1 is present in numerous cell types,
whereas caveolin-3 replaces caveolin-1 in muscle cells. The
bulk of these proteins is located in caveolae on the surface,
but they are also present on the Golgi membranes. Caveo-
lin-2 is mostly coexpressed with caveolin-1, and the two
can form heterooligomers.
The structure of caveolae depends on cholesterol, and
caveolins were found to be cholesterol-binding proteins
that end up in detergent-resistant membrane remnants,
which are generally interpreted as originating from sphin-
golipid–cholesterol rafts. Typical raft markers like glyco-
sylphosphatidylinositol proteins and glycosphingolipids
were found in caveolae under specific conditions. This,
and other indirect evidence, has suggested that caveolae
are special sphingolipid–cholesterol rafts. In the Golgi
membrane, caveolin-1 has been proposed to have a role in
lipid and protein sorting to the apical plasma membrane.
At the same time, the exciting finding of cytosolic signal-
ing molecules in caveolae has led to a wide interest in ca-
veolae as being cell surface domains where signaling is
partially regulated via the physical state of the lipids.
Many of the signaling molecules on the cytosolic surface of
the plasma membrane carry saturated C14 and C16 acyl
chains, whereas prenylated proteins are excluded. This
suggests the existence of lipid domains in the cytosolic sur-
face. The triple serine palmitoylation of caveolin-1 is not
required for its localization (Dietzen et al., 1995), although
it stabilizes the oligomers (Monier et al., 1996). One of the
unresolved issues concerning the structure of caveolae is
how caveolin on the cytosolic surface recognizes the puta-
tive sphingolipid–cholesterol rafts on the exoplasmic sur-
face. Does caveolin recognize a cholesterol-rich cytosolic
lipid domain, or could caveolin interact directly with the
hydrophobic part of the sphingolipids or cholesterol in the
opposed monolayer?
Figure 1. Model for choles-
terol recycling through the
endocytic pathway. In the lu-
menal leaflet of the trans-
Golgi network (A), sphin-
golipids and cholesterol
(blue) segregate from phos-
pholipids. In epithelial cells,
the sphingolipid–cholesterol
rafts are transported to the
apical surface, the phospho-
lipids to the basolateral sur-
face. In nonpolarized cells
both pathways target the
plasma membrane (B). From
the plasma membrane the
sphingolipids are endocytosed (from caveolae?) as are the phospholipids (from clathrin-coated buds?), into common early endosomes
(C). There the phospholipids are sorted into a recycling pathway, whereas the sphingolipids travel to the late endosomes (D), which
have obtained internal vesicles by budding from the limiting membrane. From here, the sphingolipids and cholesterol recycle to the
Golgi and the plasma membrane. This budding step may be regulated by caveolin. 
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Caveolin has been reported to bind one molecule of cho-
lesterol, and its membrane binding depends on cholesterol
(Murata et al., 1995). In addition, caveolin has been found
in soluble complexes with cholesterol and a set of chaper-
ones in the cytosol, which might suggest a role for caveolin
in intracellular cholesterol transport (Uittenbogaard et al.,
1998). The origin of the complexes is unclear. Although
newly synthesized caveolin could complex with chaperones
cotranslationally and pick up cholesterol in solution, simi-
lar to the model cholesterol-acceptor cyclodextrin, this is
unlikely because caveolin’s presence in complexes required
its acylation (Uittenbogaard and Smart, 2000), which is a
later membrane-associated event. Alternatively, the bind-
ing of acylated caveolin to the ER membrane could be un-
stable. How these caveolin complexes could obtain choles-
terol specifically from the ER and how they would deliver
this cholesterol specifically to caveolae in which it would be
confined for over an hour (Uittenbogaard and Smart, 2000)
remains enigmatic. Finally, a function of caveolins in cho-
lesterol homeostasis is suggested from the presence of ste-
rol-responsive elements in the caveolin-1 and -2 genes (Bist
et al., 1997; Fra et al., 2000).
 
Lipid Droplets
 
Lipid droplets, also termed lipid particles or lipid bodies,
are a characteristic feature of adipocytes, where they fill
most of the cytoplasm. However, they occur in every
mammalian cell. They consist of a core of triglycerides and
cholesterol esters. Their surface is covered with proteins of
which the major ones are the perilipins in adipocytes and
steroidogenic cells, and adipocyte differentiation-related
protein (ADRP
 
1
 
 also called adipophilin) in preadipocytes
and all other cells (Blanchette-Mackie et al., 1995; Servet-
nick et al., 1995; Brasaemle et al., 1997). These proteins do
not contain long hydrophobic stretches, but ADRP is acyl-
ated (Heid et al., 1996), which is probably responsible for
its droplet association. The closely related TIP47 is a cyto-
solic protein that binds to the droplets, when these are
abundant. Binding of both proteins is hydrophobic in na-
ture as it is resistant to a carbonate wash (Wolins et al.,
2001). Perilipins and ADRP cover most of the surface of
the droplet and appear to protect the core lipids from hy-
drolysis by a hormone-sensitive lipase. Upon hormonal
stimulation of lipolysis, perilipins and lipase are phosphor-
ylated by protein kinase A, which uncovers the lipids and
productively docks the lipase via a receptor, lipotransin
(Syu and Saltiel, 1999). Lipid droplets are surrounded by
a meshwork of intermediate filaments (vimentin; Mc-
Gookey and Anderson, 1983), which may serve to prevent
contacts with other droplets or other organelles (Murphy
and Vance, 1999).
The last steps in the synthesis of the core triacylglycerols
and cholesterol esters are catalyzed by related enzymes,
acyl CoA–diacylglycerol acyltransferase and acyl CoA–
cholesterol acyltransferase, which spans the ER mem-
brane five or seven times (Lin et al., 1999; Joyce et al.,
2000). The most likely mechanism by which triacylglycer-
ols and cholesterol esters end up in lipid particles is that
they first accumulate between the leaflets of the ER lipid
bilayer (Ostermeyer et al., 2001). After reaching a critical
size a lipid droplet would bud off the cytosolic side of the
ER membrane (Blanchette-Mackie et al., 1995). The hy-
drophobic core would thus be coated by a monolayer of
amphipathic lipids, regular ER membrane lipids oriented
with their hydrophobic tails towards the core and their po-
lar moiety towards the cytosol. In this scenario, it is easy to
see how ADRP from the ER (Heid et al., 1996) diffuses
laterally onto the lipid droplet, while membrane spanning
proteins and lumenal ER proteins are excluded (Fig. 2). It
is unclear how the cytosolic surface is curved and how
droplet fission occurs, but an involvement of ADRP/peri-
lipin seems likely. Overexpression of perilipins resulted in
numerous small lipid droplets (Londos et al., 1995). It
seems unlikely that ADRP and perilipins form protein
complexes in the cytosol that are subsequently filled with
lipids similar to lipoprotein assembly in the ER lumen.
There, hydrophobic lipids are transported across the aque-
ous phase by the microsomal triglyceride transfer protein.
No such protein has been identified in the cytosol.
In apparent conflict with the budding model (Fig. 2),
membrane spanning and lumenal ER proteins have been
observed on lipid droplets (Prattes et al., 2000). In addi-
tion, some groups have reported the presence of a lipid bi-
layer around the droplet (Pol et al., 2001). In milk, lipid
droplets are surrounded by a bilayer, but this is obtained
by budding of the cytosolic droplet through the plasma
membrane (Murphy and Vance, 1999). Various interpre-
tations of the data are possible. (a) Some droplets are still
physically connected to the ER membrane (Blanchette-
Mackie et al., 1995), giving the impression that the ER bi-
layer covers the droplet. (b) In some EM studies, the core
lipids are extracted during the embedding procedure (Mc-
Gookey and Anderson, 1983), and the surface monolayer
may have reoriented into a fragmented bilayer. (c) A lipid
bilayer cannot cover the triacylglycerol-cholesterol ester
core directly. Lipid particles covered by a lipid monolayer
could bud into the ER lumen, but that is not where they
are found. Alternatively, the particle could have separated
from the lumenal surface of the ER and budded back out
enveloping itself in an ER membrane. This model leaves
many questions unanswered, notably how does the differ-
ence between droplet proteins and ER proteins arise (Zin-
ser and Daum, 1995)? Also, if this model is correct, it is
difficult to see how the cytosolic lipase acquires access to
the core lipids. (d) Finally, McGookey and Anderson
(1983) have reported whorls of bilayered membranes at
specialized sites on the droplet surface, and provided evi-
dence that these were the sites of core lipid hydrolysis by
hormone-sensitive lipase (Brasaemle et al., 2000; Morimoto
et al., 2000). This hydrolysis results in a surplus of enve-
lope, which may then fold back upon itself.
The hormone-stimulated hydrolysis of cholesterol esters
may be the cause of a high concentration of free choles-
terol on the droplet surface (McGookey and Anderson,
1983; Prattes et al., 2000). Free cholesterol in droplets was
not observed by others (DiAugustine et al., 1973; Zwey-
tick et al., 2000; Pol et al., 2001). The resulting fatty acids
instantaneously leave the droplet to equilibrate with the
cytosolic fatty acid pool buffered by fatty acid binding pro-
teins. In contrast, it is not clear what happens to the drop-
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let’s surface components upon hydrolysis of the core
lipids. The surface monolayer may shrink into folded bi-
layered remnants. Indeed, upon lipolysis perilipins have
been observed to localize in small punctate structures in
the cytosol by immunofluorescence (Souza et al., 1998;
Clifford et al., 2000). Probably, the remnants are removed
by phospholipases and proteolytic enzymes.
 
Caveolins and Lipid Droplets
 
A breakthrough in our understanding of caveolins and
cholesterol may come from the present reports that caveo-
lins are found on lipid droplets (Fujimoto et al., 2001; Os-
termeyer et al., 2001; Pol et al., 2001). Why was this not ob-
served before? Actually, only the 
 
b
 
-isoform of caveolin-2
preferentially locates to the droplets (Fujimoto et al.,
2001), whereas caveolin-2
 
a
 
 localizes to the Golgi mem-
brane and, in the presence of caveolin-1, to the plasma
membrane. Caveolin-1 and -3 are constitutively located at
the plasma membrane. Caveolin-2
 
b
 
 is an endogenous,
NH
 
2
 
-terminally truncated form of caveolin-2, but engi-
neered truncation mutants of caveolins-1, -2, and -3 dis-
play the same behavior (Pol et al., 2001). Full-length cave-
olins are relocated to droplets when their concentration in
the ER is increased by overexpression, by retention at the
ER via an ER retrieval signal, or by the inhibition of vesic-
ular transport from the ER by brefeldin A.
How do caveolins reach the droplet surface? First of all,
the retention of caveolin-1 by the added retrieval signal in-
dicates that caveolin-1 is inserted into the ER membrane
and is normally transported to the plasma membrane by
the exocytic pathway (Ostermeyer et al., 2001). The sim-
plest mechanism by which it can move onto the droplet
surface is therefore by lateral diffusion through the contin-
uous cytosolic leaflet of the ER membrane (Fig. 2). Inter-
estingly, in the presence of brefeldin A caveolins redistrib-
uted to preexisting lipid droplets within 2 h (Fujimoto et
al., 2001) or 5 h (Ostermeyer et al., 2001), whereas drop-
lets have a lifetime of over 24 h in the presence of cyclo-
heximide (Pol et al., 2001). This suggests that newly
formed droplets fuse to preexisting ones, or that droplets
are in continuity with the ER. However, the fact that cave-
olin-1 was not chased out of the droplets during recovery
from brefeldin A (Ostermeyer et al., 2001), suggests that
droplets are normally not in continuity with ER. In addi-
tion, this demonstrates that lipid droplets are not an inter-
mediary station for caveolins in a rapid transport pathway
from the ER to Golgi and plasma membrane.
How are caveolins enriched on the droplet relative to
the rest of the ER membrane? (a) Caveolins could have
affinity for the droplet cholesterol that is present in the
core in the form of cholesterol ester. Although an interest-
ing possibility, reduction of cholesterol esters by 80% did
not reduce droplet caveolin (Ostermeyer et al., 2001). Re-
markably, also ADRP seems to have a cholesterol binding
site (Frolov et all., 2000). (b) Caveolins could recognize a
protein on the droplet surface or a protein comprising the
structures surrounding the droplet. The latter possibility is
supported by the observations that, upon dissolution of
the lipid droplet by Triton X-100, the caveolins stuck to
Figure 2. Lipid droplets in
mammalian cells. Lipid drop-
lets obtain their phospholipid
monolayer by budding from
the ER membrane (A). Upon
lipolysis, the droplet shrinks,
the surrounding monolayer
folds into bilayered structures
(B). The droplet can bud
through the plasma mem-
brane to yield a milk fat drop-
let surrounded by a lipid bi-
layer (C). For comparison,
lipoprotein particles are as-
sembled in the ER lumen by
the microsomal triglyceride
transfer protein (D), the lipo-
protein is transported on the
lumenal side of transport vesi-
cles (E) to the plasma mem-
brane, where lipoprotein is re-
leased into the extracellular
medium by exocytosis (F). Ca-
veolin is indicated by W. After
cotranslational insertion into
the ER membrane (Monier et
al., 1995), it can diffuse onto
the lipid droplet (A). Full-
length caveolin leaves the ER
by transport vesicles (E) to be
inserted into the plasma mem-
brane (F) by fusion of the exo-
cytic vesicle. 
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some fibrous protein right next to the droplet, and that
truncated caveolin-3 seemed to move as a wave into a
newly forming droplet (Pol et al., 2001). (c) Caveolins and
ADRP could be expelled from the ER onto the free drop-
let surface by transmembrane proteins. (d) Finally, fusion
of new lipid droplets to preexisting ones in the cytosol
would generate excess membrane relative to volume. This
imbalance might be corrected via phospholipid hydrolysis
by a phospholipase A
 
2
 
 and removal of the resulting lyso-
phospholipids and fatty acids, thus concentrating the sur-
face proteins. Apparently, under normal conditions the
exocytic route for caveolins from the ER competes effi-
ciently with lipid droplets, and the information for exo-
cytic transport resides in the NH
 
2
 
-terminal caveolin tail.
Do caveolins fulfill a physiological function in lipid
droplets? The presence of high levels of truncated caveo-
lin-3 on lipid bodies led to a dramatic redistribution of the
cellular free cholesterol from the plasma membrane to late
endosomes (Pol et al., 2001), by a mechanism similar to
that of the hydrophobic amine U18666A. As argued
above, such accumulation of cholesterol predicts an accu-
mulation of lipids with high affinity for cholesterol and a
defect in vesiculation into or out of the endosomes (Fig.
1). The caveolin mutant may sequester a protein compo-
nent that is essential for one of the endosomal budding
events. Alternatively, caveolin on the lipid droplet might
induce a signaling cascade with an inhibitory effect on en-
dosomal budding. Interestingly, during lipolysis the caveo-
lin will be in an environment rich in cholesterol and
diacylglycerol. Caveolin can activate PMA/diacylglycerol-
dependent protein kinases C via its scaffolding domain
(Oka et al., 1997; Rybin et al., 1999), which may be part of
a lipolysis-regulated signaling loop. The existence of such
a mechanism is supported by the finding of two down-
stream kinases, mitogen-activated protein kinase and
phosphatidylinositol 3-kinase on lipid droplets (Yu et al.,
1998, 2000). Is the cholesterol redistribution by truncated
caveolin-3 a bona fide function of caveolins in lipid drop-
lets? I would argue that it is not, but that this experimental
observation reflects one action of wild-type caveolin on
the plasma membrane. It suggests the exciting possibility
that caveolin in caveolae at the plasma membrane regu-
lates the recycling of cholesterol (and probably other raft
components like sphingolipids) out of the late endosomes.
Surely, more surprises will pop up in future studies of ca-
veolin function. Whether the reality will be as exciting as
the caveolin tales in the literature remains to be seen, or
better, to be investigated.
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